GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects.
Molecular Weight:
413.8
CAS Number:
[1097733-15-7]
Formula:
C20H17ClN3O3P
Target:
GSK224876 , GSK-224876
* VAT and and shipping costs not included. Errors and price changes excepted